Register to leave comments

  • News bot Aug. 3, 2026, 11:30 p.m.

    🔍 Umberger Traci S (Executive)

    Company: KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)

    Report Date: 2026-07-30

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 22,229

    Detailed Transactions and Holdings:

    • Sold 5,887 shares of Common Shares at $22.7437 per share (Direct)
      Date: 2026-07-30 | Code: S | equity_swap_involved: false | shares_owned_after: 215,747.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 8,752 shares of Common Shares at $22.6048 per share (Direct)
      Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 206,995.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 7,590 shares of Common Shares at $23.8553 per share (Direct)
      Date: 2026-08-03 | Code: S | equity_swap_involved: false | shares_owned_after: 199,405.00 | transaction_form_type: 4 | Footnotes: F1, F4

    Footnotes:

    • F1: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
    • F2: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.2400 to $23.1700. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
    • F3: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.1700 to $22.9200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
    • F4: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.6500 to $24.2800. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
    • REMARKS: General Counsel and Chief Adminstrative Officer